Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/11000/3369
Influencia sobre la evolución del cociente CD4/CD8 de la utilización de distintas pautas de
tratamiento antirretroviral
Título : Influencia sobre la evolución del cociente CD4/CD8 de la utilización de distintas pautas de
tratamiento antirretroviral |
Autor : Terol Esclápez, Gertrudis |
Tutor: Masiá Canuto, María del Mar |
Fecha de publicación: 2015-09-16 |
URI : http://hdl.handle.net/11000/3369 |
Resumen :
BACKGROUND: CD4/CD8 ratio is a potential marker of immune activation and risk of developing non-
AIDS events. A low ratio is associated with persistent chronic immune dysfunction, T cell activation and immune senescence. An optimal response to antirretroviral (AVR) therapy requires normalization of CD4/CD8 ratio, but this only occurs in a minority of patients.
END POINT: To determine the evolution of CD4/CD8 ratio in HIV patients on effective AVR therapy in
relation to the different ARV regimens used and whether there are differences among them or not.
METHODS: A cohort of HIV patients from 1980-2014 is analyzed, receiving suppressor regimens based on non-nucleoside reverse-transcriptase inhibitors (NNRTI), Protease Inhibitors (PI) or integrase inhibitors (II) with a duration of at least 6 months and a CD4/CD8 ratio ≤ 1, at the begining of the different each regimen.
RESULTS: There were 880 treatment regimens studied, incluiding 502 patients with a mean age of 41.95 years, mostly men (78.49%) of Spanish nationality (81.28%). The HIV infection risk factors were: 46.02% users of intravenous drugs, 23.51% homosexuals and 22.51% heterosexuals. Hepatitis C co-infection, was found in %. Broadly, with each treatment regimen, there is a trend towards and increase of the CD4 / CD8 ratio during the follow up, and a minority of patiens have achieved the goal of normalization (ratio ≥ 1). The different treatment regimens, seem to determine a different evolution of the cd4/cd8 ratio, observing a better trend with the II regimen, but these data are yet to be analyzed .
CONCLUSIONS: Finding differences among ARV regimens, could contribute to develop better therapies targeting immune restoration in HIV patients.
|
Palabras clave/Materias: Cociente CD4/CD8, VIH, Tratamiento antirretroviral, Linfocitos |
Área de conocimiento : CDU: Ciencias aplicadas: Medicina |
Tipo documento : application/pdf |
Derechos de acceso: info:eu-repo/semantics/openAccess |
Aparece en las colecciones: TFM-M.U Enfermedades Infecciosas y Salud Internacional
|
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.